Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
18.9M
-
Shares change
-
+504K
-
Total reported value, excl. options
-
$115M
-
Value change
-
+$2.93M
-
Number of buys
-
23
-
Number of sells
-
-15
-
Price
-
$6.10
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q4 2016
54 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q4 2016.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.9M shares
.
Largest 10 shareholders include NEA Management Company, LLC (8.58M shares), BVF INC/IL (2.83M shares), WELLINGTON MANAGEMENT GROUP LLP (2.8M shares), FRANKLIN RESOURCES INC (1M shares), SPHERA FUNDS MANAGEMENT LTD. (746K shares), VANGUARD GROUP INC (424K shares), BlackRock Fund Advisors (398K shares), BAKER BROS. ADVISORS LP (381K shares), Cormorant Asset Management, LLC (287K shares), and Candriam Luxembourg S.C.A. (160K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.